ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Castle Biosciences Inc

Castle Biosciences Inc (CSTL)

22.15
0.87
(4.09%)
At close: March 28 04:00PM
22.15
0.87
( 4.09% )
After Hours: 04:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
22.15
Bid
21.71
Ask
22.59
Volume
380,382
21.33 Day's Range 22.52
9.2601 52 Week Range 26.70
Market Cap
Previous Close
21.28
Open
21.37
Last Trade
57
@
22.15
Last Trade Time
16:20:00
Financial Volume
$ 8,469,957
VWAP
22.267
Average Volume (3m)
257,948
Shares Outstanding
27,449,983
Dividend Yield
-
PE Ratio
-10.58
Earnings Per Share (EPS)
-2.09
Revenue
219.79M
Net Profit
-57.47M

About Castle Biosciences Inc

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Wilmington, Delaware, USA
Founded
1970
Castle Biosciences Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CSTL. The last closing price for Castle Biosciences was $21.28. Over the last year, Castle Biosciences shares have traded in a share price range of $ 9.2601 to $ 26.70.

Castle Biosciences currently has 27,449,983 shares outstanding. The market capitalization of Castle Biosciences is $608.02 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -10.58.

CSTL Latest News

Castle Biosciences Announces Updates to its Board of Directors

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Rodney Cotton has been appointed to its board of...

Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year

Company honored for creating an exceptional, people-first culture that empowers employees and fosters trust, transparency and authenticity Castle Biosciences, Inc. (Nasdaq: CSTL), a company...

Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB

Castle’s second presentation at SSO 2024 shows that in a study of 979 patients, DecisionDx-Melanoma demonstrated clinical use value in patients with TI cutaneous melanoma (CM), identifying...

Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy

The consensus guidelines were drafted by a multidisciplinary panel of radiation oncologists and dermatologists/Mohs micrographic surgeons with expertise in cutaneous squamous cell carcinoma (SCC...

New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older

Study data show that one-third of the IDgenetix-guided medication recommendations were due to drug-drug interactions and lifestyle factors, demonstrating the value of this additional information...

Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Company’s executive management is scheduled to...

Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting

Castle’s presentations at AAD include the latest findings from the Company’s ongoing collaboration with the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program...

In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups

Largest study of gene expression profile testing in patients with high-risk cutaneous squamous cell carcinoma (SCC) supports test’s ability to provide clinically actionable risk stratification to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.637.9434697855820.5222.5220.1220637121.02196187CS
4-2.7-10.865191146924.8524.873917.4231414920.15866928CS
121.326.3370139222320.8325.617.4225794821.56573816CS
265.7434.978671541716.4125.612.0726351719.27411793CS
52-0.27-1.2042818911722.4226.79.260138491817.87131283CS
156-37.04-62.57813819959.1978.929.260128356329.77077299CS
2602.1510.7520107.699.260125464734.67955528CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.12
(62.34%)
1.94M
SBFMSunshine Biopharma Inc
$ 0.0831
(37.36%)
10.87M
UBXGU BX Technology Ltd
 4.55
(10.98%)
2.79k
AZA2Z Smart Technologies Corporation
$ 0.6372
(9.26%)
1.84k
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.2025
(8.87%)
328.98k
XTKGX3 Holdings Company Ltd
$ 0.6599
(-33.35%)
813.9k
PLSEPulse Biosciences Inc
$ 7.4186
(-14.83%)
5.8k
APLTApplied Therapeutics Inc
$ 5.88
(-13.53%)
57.72k
VVOSVivos Therapeutics Inc
$ 4.20
(-13.04%)
12.89k
MVLAMovella Holdings Inc
$ 0.055
(-11.86%)
106.9k
SBFMSunshine Biopharma Inc
$ 0.0831
(37.36%)
10.87M
CRKNCrown Electrokinetics Corporation
$ 0.0619
(3.34%)
4.29M
AAPLApple Inc
$ 171.35
(-0.08%)
3.18M
MSFTMicrosoft Corporation
$ 420.00
(-0.17%)
2.51M
INTCIntel Corporation
$ 44.13
(-0.09%)
2.33M

Discussion

View Full Feed
dennisdave dennisdave 2 minutes ago
Nope!; ). Approval brings attention and interest that can be responded to. Approval allows patients to access set aside funds in the UK immediately. Approval allows Linda to talk about a PLATFORM treatment that initially can be considered for study and off label use in all solid tumor tumors. Approv
NWBO
strawpatch strawpatch 2 minutes ago
I think P3 is the closest catalyst. Likely not able to start until the Fall - so still a ways away. But I think that is probably closest. But this study should be relatively quick for a P3 study. Patient in respiratory distress either lives or dies - not likely needing year follow up etc.
TSOI
georgie18 georgie18 3 minutes ago
Thank you...watching my Yankees getting their asses kicked so far...🥳
maperatpogi maperatpogi 3 minutes ago
Have a nice weekend
and a glorious Easter Sunday!!!

Have some fun humterdave!
IGPK
louieforpar louieforpar 3 minutes ago
BREAKING NEWS!!!!!EVIDENCE OF VOTER FRAUD!!!!



Georgia GOP vice chairman who claimed 2020 voter fraud fined for voting illegally 9 times

Georgia Republican Party's first vice chairman, Brian K. Pritchard, committed voter fraud by casting a ballot while
DJT
sage4 sage4 3 minutes ago
We were at $1 billion MC(or $12/share) 18 month ago. sigh.....
AVXL
$$$$$$$ $$$$$$$ 4 minutes ago
once again for the slow one in the room https://www.otcshortreport.com/company/SPZI
SPZI
TIMGZ TIMGZ 4 minutes ago
I AM HOLDING, WILL BE BACK IN UPPER 2s in FEW DAYS. BUT A LOT OF CAPITAL WILL BE TIED UP*****
WELCOME TO THE PREMIUM QUOTE
PennyMillions852 PennyMillions852 4 minutes ago
I’m laughing at YOU!!! Go mow the lawn or something…..
CBIA
Moon Bot Moon Bot 4 minutes ago
lol this has to take so much energy for you guys to be such douchebags, no one cares what you have to say you're pathetic, Such a waste of time on all your ends, get over it.
MONI
WizardVoyager39 WizardVoyager39 4 minutes ago
Sure did.
PAOG
moola26 moola26 4 minutes ago
Another long winded ( I’m sure ) post that is absolutely drivel. Wont read

Majority holding strong:)
hookrider hookrider 5 minutes ago
DesertDrifter: I use WD-40 in other places. Keeps things up to par & hard!!!!
lakers17 lakers17 5 minutes ago
I already owned NWPN but grabbed more .0001s yesterday and today. Nice to have a .0001 average. lOL Total lotto play. Too many of these Tweets which seem to have replaced PRs never turn out.
NWPN
blackhawks blackhawks 5 minutes ago
Joe's economy has full employment, low unemployment, healthy GDP, manufacturing investment at a record pace and an infrastructure bill that is no doubt repairing and building in your run down state.
Zorro Zorro 6 minutes ago
SBFM coming to life
SBFM
GARYM1 GARYM1 6 minutes ago
It's almost like S7 is being treated like the boy who cried wolf.
The wolf (AI ) is here but nobody cares.
SEV
powerbattles powerbattles 6 minutes ago
EMGE, KOAN, AND APOLLO Have completed a reverse triangular merger. Right now, they are operating as separate entities until the completion of the 251(g) reorganization of the new company APOLLO. Once the 251(g) process is completed. EMGE will be exchanged for KOAN shares. EMGE and KOAN become the su
EMGE
weedtrader420 weedtrader420 6 minutes ago
Hallelujah!
DOGEUSD
Louinjaxxx Louinjaxxx 7 minutes ago
True. Note: not all longs are pumpers.
AXXA
motleytool motleytool 7 minutes ago
Read the financials. The officers were buying shares right before this announcement. Musk would pull these same stunts to fry the shorts and it always worked.
GMDA
MadBrewer MadBrewer 7 minutes ago
I put it in after close for an opening snag on Monday.
Yes those 83m was intriguing enough for a buck but,
it's still a no-bid trip.

Cheers
GTCH

Your Recent History

Delayed Upgrade Clock